Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Trends in Cancer|March 7, 2018
Exploring Stem Cell Heterogeneity in Chronic Myeloid LeukemiaChinmay Munje, Mhairi CoplandCancers|November 12, 2013
A novel therapeutic strategy for the treatment of glioma, combining chemical and molecular targeting of hsp90aAdi Mehta, Leroy Shervington, Chinmay Munje, et al.Cancer Investigation|June 14, 2013
The complexity of identifying cancer stem cell biomarkersZarine Khan, Amal Shervington, Chinmay Munje, et al.Cancer Investigation|March 10, 2010
Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma?Nichola Cruickshanks, Leroy Shervington, Rahima Patel, et al.Gene Expression|December 6, 2015
Cord Blood-Derived Quiescent CD34+ Cells Are More Transcriptionally Matched to AML Blasts Than Cytokine-Induced Normal Human Hematopoietic CD34+ CellsChinmay Munje, Robert K Hills, Anthony Whetton, et al.Inflammatory Bowel Diseases|December 2, 2025
Clinical Response for 12 Months or More to the First Advanced Therapy is Associated with a Significant Decrease in the Long-Term Risk of Hospitalization: A Nation-Wide Analysis of Patients From the UK Inflammatory Bowel Disease (IBD) BioResourceKaung Yan, Sudheer Kumar Vuyyuru, Adam Taylor, et al.Cancers|November 11, 2022
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication TherapyEduardo Gómez-Castañeda, Lisa E M Hopcroft, Simon Rogers, et al.Blood|October 4, 2013
Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signalingPaul S Hole, Joanna Zabkiewicz, Chinmay Munje, et al.Cancers|October 14, 2022
The Spliceosome: A New Therapeutic Target in Chronic Myeloid LeukaemiaBenjamin Lebecque, Celine Bourgne, Chinmay Munje, et al.Leukemia|January 4, 2020
CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapyRoss Kinstrie, Gillian A Horne, Heather Morrison, et al.Pageof 2